Scalper1 News
Generic-drug giant Mylan (MYL) announced Wednesday that it had bid $205 a share in cash and stock for sizable peer Perrigo, sending both stock soaring. Although Perrigo (PRGO) apparently hadn’t agreed to a deal, Mylan’s statement indicated they’d been talking. “This proposal is the culmination of a number of prior discussions between Mylan and Perrigo about the compelling strategic and financial logic of this combination,” Mylan CEO Robert Coury Scalper1 News
Scalper1 News